118 related articles for article (PubMed ID: 28677425)
1. IKBKE promotes glioblastoma progression by establishing the regulatory feedback loop of IKBKE/YAP1/miR-Let-7b/i.
Zhang Z; Lu J; Guo G; Yang Y; Dong S; Liu Y; Nan Y; Zhong Y; Yu K; Huang Q
Tumour Biol; 2017 Jul; 39(7):1010428317705575. PubMed ID: 28677425
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs let-7b/i suppress human glioma cell invasion and migration by targeting IKBKE directly.
Tian Y; Hao S; Ye M; Zhang A; Nan Y; Wang G; Jia Z; Yu K; Guo L; Pu P; Huang Q; Zhong Y
Biochem Biophys Res Commun; 2015 Mar; 458(2):307-12. PubMed ID: 25656572
[TBL] [Abstract][Full Text] [Related]
3. A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.
Wu DW; Wang YC; Wang L; Chen CY; Lee H
Theranostics; 2018; 8(5):1256-1269. PubMed ID: 29507618
[No Abstract] [Full Text] [Related]
4. Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p.
Lee H; Hwang SJ; Kim HR; Shin CH; Choi KH; Joung JG; Kim HH
Biochim Biophys Acta; 2016 Apr; 1859(4):599-611. PubMed ID: 26923924
[TBL] [Abstract][Full Text] [Related]
5. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
8. YAP1 inhibits circRNA-000425 expression and thus promotes oncogenic activities of miR-17 and miR-106.
Liu Z; Huang S; Cao Y; Yao Y; Li J; Chen J; Jiang B; Yuan X; Xiang X; Xiong J; Deng J
Biochem Biophys Res Commun; 2018 Sep; 503(4):2370-2375. PubMed ID: 30017188
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-622 suppresses the proliferation of glioma cells by targeting YAP1.
Xu J; Ma B; Chen G; Wei D; Li L; Hu W
J Cell Biochem; 2018 Mar; 119(3):2492-2500. PubMed ID: 28796324
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1.
Deng J; Lei W; Xiang X; Zhang L; Yu F; Chen J; Feng M; Xiong J
Tumour Biol; 2015 Sep; 36(9):6823-31. PubMed ID: 25846731
[TBL] [Abstract][Full Text] [Related]
11. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1.
Zhang H; Liu H; Bi H
Oncol Rep; 2017 Aug; 38(2):843-849. PubMed ID: 28677785
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
14. SRSF3-regulated miR-132/212 controls cell migration and invasion by targeting YAP1.
Kim HR; Hwang SJ; Shin CH; Choi KH; Ohn T; Kim HH
Exp Cell Res; 2017 Sep; 358(2):161-170. PubMed ID: 28624413
[TBL] [Abstract][Full Text] [Related]
15. PTPN14, a target gene of miR-4295, restricts the growth and invasion of osteosarcoma cells through inactivation of YAP1 signalling.
Liang G; Duan C; He J; Ma W; Dai X
Clin Exp Pharmacol Physiol; 2020 Jul; 47(7):1301-1310. PubMed ID: 32141101
[TBL] [Abstract][Full Text] [Related]
16. Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma.
Kang W; Tong JH; Lung RW; Dong Y; Zhao J; Liang Q; Zhang L; Pan Y; Yang W; Pang JC; Cheng AS; Yu J; To KF
Mol Cancer; 2015 Feb; 14():52. PubMed ID: 25743273
[TBL] [Abstract][Full Text] [Related]
17. Silencing IKBKE inhibits the migration and invasion of glioblastoma by promoting Snail1 degradation.
Liu Y; Guo G; Lu Y; Chen X; Zhu L; Zhao L; Li C; Zhang Z; Jin X; Dong J; Yang X; Huang Q
Clin Transl Oncol; 2022 May; 24(5):816-828. PubMed ID: 34741724
[TBL] [Abstract][Full Text] [Related]
18. Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.
Zhang M; Zeng J; Zhao Z; Liu Z
Mol Carcinog; 2017 Mar; 56(3):821-832. PubMed ID: 27500472
[TBL] [Abstract][Full Text] [Related]
19. CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway.
Wang X; Lu J; Li J; Liu Y; Guo G; Huang Q
J Transl Med; 2021 Sep; 19(1):396. PubMed ID: 34544426
[TBL] [Abstract][Full Text] [Related]
20. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
